US Broker Ratings

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing proposition for investors focused on the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With..

Stevanato Group S.p.A. (STVN) Stock Analysis: Uncovering a 37% Upside Potential in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian stalwart in the healthcare sector, has captured investors’ attention with its promising growth potential, reflected in a striking 37.05%..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and Revenue Growth Propel Healthcare Giant Forward

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, operates primarily in the medical distribution industry. With a market capitalization of $55.72 billion, the..

Insulet Corporation (PODD) Stock Analysis: Impressive Growth Potential with a 51.82% Upside

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, is making waves with its innovative insulin delivery systems. With a market..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a Healthcare Giant with a 71.4% ROE

Novo Nordisk A/S (NVO), a prominent player in the healthcare sector, has long been a beacon of innovation in the pharmaceutical industry. With its extensive reach..

Glaukos Corporation (GKOS) Stock Analysis: High Growth and Strong Buy Ratings Drive Investor Interest

Glaukos Corporation (GKOS), a key player in the medical devices industry, is gaining significant attention from investors, thanks to its robust growth metrics and strong endorsement..

Waters Corporation (WAT) Stock Analysis: Navigating a 91.4% Revenue Surge with Analyst Optimism

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with its robust growth trajectory and favorable..

Penumbra, Inc. (PEN) Stock Analysis: A 15% Upside Potential in the Medical Devices Sector

Penumbra, Inc. (NYSE: PEN) stands out as a dynamic player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $12.45..

Grifols, S.A. (GRFS) Stock Analysis: Potential Upside of 47% Sparks Investor Interest

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector and a key contributor to the drug manufacturing industry, is captivating the attention of investors..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating the 260% Revenue Growth Amidst a Volatile Market

Moderna, Inc. (NASDAQ: MRNA) has become a household name in the biotechnology industry, especially following its pivotal role in developing the COVID-19 vaccine. As of the..

ICON plc (ICLR) Stock Analysis: Navigating Growth in the Healthcare Sector with Strategic Insights

ICON plc (ICLR), a prominent player in the healthcare sector, is carving a niche in the diagnostics and research industry. With its headquarters in Dublin, Ireland,..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with Strong Buy Ratings

CVS Health Corporation (CVS), a stalwart in the healthcare sector, continues to be a focal point for investors looking to capitalize on the evolving landscape of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth and Market Position Amid a 26.5% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP), a leading player in the healthcare sector, has been catching the eye of investors with its robust revenue growth and impressive..

Elanco Animal Health (ELAN) Stock Analysis: A 21.52% Upside Potential in the Booming Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) is turning heads in the healthcare sector, particularly within the niche of animal health where it operates as a key..

United Therapeutics Corporation (UTHR) Stock Analysis: A 22.59% Potential Upside with Robust Product Pipeline

Investors seeking opportunities in the healthcare sector might find United Therapeutics Corporation (NASDAQ: UTHR) an intriguing prospect. With a market capitalization of $23.03 billion, United Therapeutics..

Encompass Health Corporation (EHC) Stock Analysis: Robust Growth Potential with a 38.66% Upside

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, stands at a critical juncture for investors seeking stable growth and substantial upside potential...

IDEXX Laboratories (IDXX) Stock Analysis: Uncovering a Potential 28.58% Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a key player in the Healthcare sector’s Diagnostics & Research industry, offers a compelling opportunity for investors seeking growth in the..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating the Challenges with Strategic Insights

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is a key name in the drug manufacturing industry, focusing on both specialty..

The Ensign Group, Inc. (ENSG) Stock Analysis: Eyeing a 35% Potential Upside with Strong Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, continues to capture investor attention with its robust growth metrics and a promising..

Biogen Inc. (BIIB) Stock Analysis: Evaluating Growth Potential Amidst Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB), a leader in the healthcare sector, is currently in the spotlight for investors seeking growth potential in the drug manufacturing industry. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds